Pain Therapeutics (PTIE) Stock: Gaining Ahead Of Investor Call

Pain Therapeutics, Inc. (NASDAQ: PTIE) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The comapny recently announced an invetor call, promising to provide a strategic update. It seems as though this is what is exciting investors this morning. Today, we’ll talk about: The investor call; what we’re … Read more

Pain Therapeutics (PTIE) Stock: Falling Hard On Offering

After flying in the market yesterday due to a grant announcement, Pain Therapeutics, Inc. (NASDAQ: PTIE) is seeing dramatic declines in the market this morning. The declines are ultimately the result of news surrounding a dilutive offering. Of course, investors never respond well to dilution. Today, we’ll talk about: The offering; what we’re seeing from PTIE … Read more

Pain Therapeutics (PTIE) Stock: Rocketing On Alzheimer’s Grant

Pain Therapeutics, Inc. (NASDAQ: PTIE) is rocketing toward the top early on in the trading session this morning, and fro good reason. The company announced that it has been awarded a grant surrounding its Alzheimer’s disease treatment that is under development. Of course, the news excited investors, sending the stock on a tear for the … Read more

Pain Therapeutics (PTIE) Stock: Falling Hard On FDA Rejection

Pain Therapeutics, Inc. (NASDAQ: PTIE) is having an overwhelmingly rough start to the trading session in the pre-market hours this morning, and for good reason. The company announced that it has received a Complete Response Letter (CRL) from the United States Food and Drug Administration (FDA), surrounding its New Drug Application (NDA) for REMOXY. Unforutnatley, … Read more

Pain Therapeutics (PTIE) Stock: Skyrocketing On Positive Clinical Results

Pain Therapeutics, Inc. (NASDAQ: PTIE) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced overwhelmingly positive data surrounding a key clinical candidate, leading to excitement among investors and sending the stock screaming for the top. Today, we’ll talk about the results, what we’re seeing from … Read more

Pain Therapeutics (PTIE) Stock: Gaining Big On Successful Study Completion

Pain Therapeutics, Inc. (NASDAQ: PTIE) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced the successful completion of a Phase 1 clinical trial, leading to excitement among investors who are sending the stock on an explosive ride upward. Of course, our partners at Trade Ideas … Read more